These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8631606)

  • 1. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone.
    Pinski J; Schally AV; Groot K; Halmos G; Szepeshazi K; Zarandi M; Armatis P
    J Natl Cancer Inst; 1995 Dec; 87(23):1787-94. PubMed ID: 7473836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
    J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
    Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K
    Int J Cancer; 1993 Dec; 55(6):963-7. PubMed ID: 7902829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR; Radulovic S; Groot K; Schally AV
    Prostate; 1992; 20(4):269-80. PubMed ID: 1376910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160.
    Mishima M; Yano T; Jimbo H; Yano N; Morita Y; Yoshikawa H; Schally AV; Taketani Y
    Am J Obstet Gynecol; 1999 Sep; 181(3):583-90. PubMed ID: 10486467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice.
    Pinski J; Halmos G; Schally AV
    Cancer Lett; 1993 Jul; 71(1-3):189-96. PubMed ID: 8103419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
    Weckbecker G; Liu R; Tolcsvai L; Bruns C
    Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-0,0']-(SP-4-2) in athymic rats with osteosarcoma.
    Conzemius MG; Graham JC; Haynes JS; Graham CA
    Am J Vet Res; 2000 Jun; 61(6):646-50. PubMed ID: 10850839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
    Halmos G; Schally AV; Bernardino AL; Varga JL
    Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
    Radulovic S; Miller G; Schally AV
    Cancer Res; 1991 Nov; 51(21):6006-9. PubMed ID: 1682040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate.
    Qin Y; Ertl T; Groot K; Horvath J; Cai RZ; Schally AV
    Int J Cancer; 1995 Mar; 60(5):694-700. PubMed ID: 7860145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
    Radulovic S; Schally AV; Reile H; Halmos G; Szepeshazi K; Groot K; Milovanovic S; Miller G; Yano T
    Acta Oncol; 1994; 33(6):693-701. PubMed ID: 7946450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
    Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.